---
title: Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
  Reply
date: '2024-05-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38810204/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240530181439&v=2.18.0.post9+e462414
source: N Engl J Med
description: No ...
disable_comments: true
---
No ...